Stockholders’ Equity (Details) - Schedule of Company’s Outstanding Warrants and Options |
9 Months Ended |
|---|---|
|
Sep. 30, 2024
USD ($)
$ / shares
shares
| |
| $1.43 - $60.00 [Member] | Warrant [Member] | |
| Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
| Number of Warrants Outstanding | 4,896,219 |
| Warrants Weighted Average Remaining Contractual Life (in years) | 4 years 9 months 14 days |
| Warrants Weighted Average Exercise Price (in Dollars per share) | $ / shares | $ 1.64 |
| Number of Warrants Exercisable | 4,896,219 |
| Intrinsic Value (in Dollars) | $ | |
| $39.60 [Member] | Stock Option [Member] | |
| Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
| Number of Warrants Outstanding | 3,333 |
| Warrants Weighted Average Remaining Contractual Life (in years) | 1 month 28 days |
| Warrants Weighted Average Exercise Price (in Dollars per share) | $ / shares | $ 39.6 |
| Number of Warrants Exercisable | 3,333 |
| Intrinsic Value (in Dollars) | $ |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|